Resolving the mysteries of the renin-angiotensin system in diabetes

Abstract

Get full access to this article

View all access options for this article.

References

Luetscher JA , Kraemer FB , Wilson DM , Schwartz HC , Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. N Engl J Med 1985; 312:1412-17.

Lewis EJ , Hunsicker LG , Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.

Brenner BM , Cooper ME , deZeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.

Veniant M. , Menard J. , Bruneval P. , Morley S. , Gonzales MF , Mullins J. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest 1996 ;98:1966-70.

Kim S. , Hosoi M. , Nakajima K. , Yamamoto K. Immunological evidence that kidney is primary source of circulating inactive prorenin in rats. Am J Physiol Renal Physiol 1991; 260:E526-E536.

Nguyen G. , Delarue F. , Burckle C. , Bouzhir L. , Giller T. , Sraer J. -D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109:1417-27.

Suzuki F. , Hayakawa M. , Nakagawa T. et al. Human prorenin has `gate and handle` regions for its non-proteolytic activation. J Biol Chem 2003;278:22217-22.

Ichihara A. , Kaneshiro Y. , Suzuki F. Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension. Expert Opin Investig Drugs 2006;15:1137-9.

Ichihara A. , Kaneshiro Y. , Takemitsu T. et al. Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006;47:894-900.

10.

Ichihara A. , Kaneshiro Y. , Takemitsu T. et al. Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006;17:2495-503.

11.

Ichihara A. , Suzuki F. , Nakagawa T. et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 2006;17:1950-61.